|
Korean treatment recommendations for patients with axial spondyloarthritis
Mi Ryoung Seo, Jina Yeo, Jun Won Park, Yeon-Ah Lee, Ju Ho Lee, Eun Ha Kang, Seon Mi Ji, Seong-Ryul Kwon, Seong-Kyu Kim, Tae-Jong Kim, Tae-Hwan Kim, Hye Won Kim, Min-Chan Park, Kichul Shin, Sang-Hoon Lee, Eun Young Lee, Hoon Suk Cha, Seung Cheol Shim, Youngim Yoon, Seung Ho Lee, Jun Hong Lim, Han Joo Baek; on behalf of the Korean Society of Spondyloarthritis Research
Korean J Intern Med. 2024;39(1):200-200. Published online November 10, 2023
|
|
|
Korean treatment recommendations for patients with axial spondyloarthritis
[corrected-article]
Mi Ryoung Seo, Jina Yeo, Jun Won Park, Yeon-Ah Lee, Ju Ho Lee, Eun Ha Kang, Seon Mi Ji, Seong-Ryul Kwon, Seong-Kyu Kim, Tae-Jong Kim, Tae-Hwan Kim, Hye Won Kim, Min-Chan Park, Kichul Shin, Sang-Hoon Lee, Eun Young Lee, Hoon Suk Cha, Seung Cheol Shim, Youngim Yoon, Seung Ho Lee, Jun Hong Lim, Han Joo Baek; on behalf of the Korean Society of Spondyloarthritis Research
Korean J Intern Med. 2023;38(5):620-640. Published online July 24, 2023
We aimed to develop evidence-based recommendations for treating axial spondylarthritis (axSpA) in Korea. The development committee was constructed, key clinical questions were determined, and the evidence was searched through online databases including MEDLINE, Embase, Cochrane, KoreaMed, and Kmbase..
|
|
|
Recommendations for the management of patients with systemic rheumatic diseases during the coronavirus disease pandemic
Mi Ryoung Seo, Ji-Won Kim, Eun-Jung Park, Seung Min Jung, Yoon-Kyoung Sung, Hyungjin Kim, Gunwoo Kim, Hyun-Sook Kim, Myeung-Su Lee, Jisoo Lee, Ji An Hur, Bum Sik Chin, Joong Sik Eom, Han Joo Baek; The Korean College of Rheumatology working group
Korean J Intern Med. 2020;35(6):1317-1332. Published online September 15, 2020
Patients with systemic rheumatic diseases (SRD) are vulnerable for coronavirus disease (COVID-19). The Korean College of Rheumatology recognized the urgent need to develop recommendations for rheumatologists and other physicians to manage patients with SRD during the COVID-19 pandemic. The working g..
|
|
|
Rheumatology
Clinical phenotypes of Korean patients with Behcet disease according to gender, age at onset,
and HLA-B51
Hee Jung Ryu, Mi Ryoung Seo, Hyo Jin Choi, Han Joo Baek
Korean J Intern Med. 2018;33(5):1025-1031. Published online January 12, 2017
Background/Aims: The clinical manifestations of Behcet disease (BD) have been reported to differ according to country, region, and race. Gender, onset age, and human leukocyte antigen (HLA)-B51 have also been known as the factors that influence the clinical features of BD. The aim of this study is t..
|
|
|
Validation and reliability of a Behcet’s Syndrome Activity Scale in Korea
Hyo Jin Choi, Mi Ryoung Seo, Hee Jung Ryu, Han Joo Baek
Korean J Intern Med. 2016;31(1):170-175. Published online December 28, 2015
Background/Aims: We prepared a cross-cultural adaptation of the Behcet’s Syndrome Activity Scale (BSAS) and evaluated its reliability and validity in Korea.
Methods: Fifty patients with Behcet’s disease (BD) who attended the Rheumatology Clinic of Gachon University Gil Medical Center were include..
|
|
|
Cross-cultural adaptation and validation of the Behcet’s Disease Current Activity Form in Korea
Hyo Jin Choi, Mi Ryoung Seo, Hee Jung Ryu, Han Joo Baek
Korean J Intern Med. 2015;30(5):714-718. Published online August 27, 2015
Background/Aims: This study was undertaken to perform a cross-cultural adaptation of the Behcet’s Disease Current Activity Form (BDCAF, version 2006) questionnaire to the Korean language and to evaluate its reliability and validity in a population of Korean patients with Behcet’s disease (BD).
..
|
|
|
Literature review of non-pharmacological treatment for patients with axial spondyloarthritis
Jina Yeo, Mi Ryoung Seo, Jun Won Park, Yeon-Ah Lee, Ju Ho Lee, Eun Ha Kang, Seon Mi Ji, Han Joo Baek
Received November 10, 2023 Accepted February 26, 2024 Published online May 27, 2024
Axial spondyloarthritis (axSpA) is a chronic inflammatory disorder affecting the sacroiliac joints and axial spine. Along with pharmacotherapy, non-pharmacological interventions for axSpA are crucial and constitute the cornerstone of treatment. Here, we review the evidence for non-pharmacological tr..
|
|
|
